These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23632777)

  • 21. Livin gene plays a role in drug resistance of colon cancer cells.
    Wang X; Xu J; Ju S; Ni H; Zhu J; Wang H
    Clin Biochem; 2010 May; 43(7-8):655-60. PubMed ID: 20171199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between expression of Livin and the biological behavior of human oral squamous cell carcinoma.
    Lee DH; Yoon TM; Kim SA; Park YL; Lee KH; Lim SC; Lee JK; Joο YE
    Oncol Rep; 2014 Dec; 32(6):2453-60. PubMed ID: 25242075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.
    Ma JF; Liu L; Yang WJ; Zang LN; Xi YM
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1102-9. PubMed ID: 23661525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells.
    Crnković-Mertens I; Muley T; Meister M; Hartenstein B; Semzow J; Butz K; Hoppe-Seyler F
    Lung Cancer; 2006 Nov; 54(2):135-42. PubMed ID: 16965834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
    Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC
    Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
    Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
    Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.
    Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
    Mol Cell Biochem; 2014 Sep; 394(1-2):109-18. PubMed ID: 24833469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
    Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
    Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of livin gene suppression by genistein on apoptosis, cell cycle and proliferation of malignant melanoma LiBr cells].
    Yang Y; Wang H; Wang J; Li X; Ma M; Yang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1163-7. PubMed ID: 22931613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.
    Yu L; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):625-30. PubMed ID: 19821098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
    Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
    Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.